Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
School of Law, Psychology and Social Work, Örebro University, Örebro, Sweden.
JAMA Netw Open. 2023 Jul 3;6(7):e2322069. doi: 10.1001/jamanetworkopen.2023.22069.
Nonsuicidal self-injury is prevalent in adolescence and associated with adverse clinical outcomes. Effective interventions that are brief, transportable, and scalable are lacking.
To test the hypotheses that an internet-delivered emotion regulation individual therapy for adolescents delivered adjunctive to treatment as usual is superior to treatment as usual only in reducing nonsuicidal self-injury and that improvements in emotion regulation mediate these treatment effects.
DESIGN, SETTING, AND PARTICIPANTS: This 3-site, single-masked, randomized superiority trial enrolled participants from November 20, 2017, to April 9, 2020. Eligible participants were aged between 13 and 17 years and met diagnostic criteria for nonsuicidal self-injury disorder; they were enrolled as a mixed cohort of consecutive patients and volunteers. Parents participated in parallel to their children. The primary end point was at 1 month after treatment. Participants were followed up at 3 months posttreatment. Data collection ended in January 2021.
Twelve weeks of therapist-guided, internet-delivered emotion regulation individual therapy delivered adjunctive to treatment as usual vs treatment as usual only.
Primary outcome was the youth version of the Deliberate Self-harm Inventory, both self-reported by participants prior to treatment, once every week during treatment, and for 4 weeks posttreatment, and clinician-rated by masked assessors prior to treatment and at 1 and 3 months posttreatment.
A total of 166 adolescents (mean [SD] age, 15.0 [1.2] years; 154 [92.8%] female) were randomized to internet-delivered emotion regulation therapy plus treatment as usual (84 participants) or treatment as usual only (82 participants). The experimental intervention was superior to the control condition in reducing clinician-rated nonsuicidal self-injury (82% vs 47% reduction; incidence rate ratio, 0.34; 95% CI, 0.20-0.57) from pretreatment to 1-month posttreatment. These results were maintained at 3-month posttreatment. Improvements in emotion dysregulation mediated improvements in self-injury during treatment.
In this randomized clinical trial, a 12-week, therapist-guided, internet-delivered emotion regulation therapy delivered adjunctive to treatment as usual was efficacious in reducing self-injury, and mediation analysis supported the theorized role of emotion regulation as the mechanism of change in this treatment. This treatment may increase availability of evidence-based psychological treatments for adolescents with nonsuicidal self-injury.
ClinicalTrials.gov Identifier: NCT03353961.
非自杀性自伤在青少年中很普遍,与不良的临床结果有关。缺乏简短、可移植和可扩展的有效干预措施。
测试以下假设,即互联网提供的青少年情绪调节个体治疗,作为辅助治疗常规治疗,在减少非自杀性自伤方面优于常规治疗,并且情绪调节的改善可以介导这些治疗效果。
设计、地点和参与者:这是一项 3 个地点、单盲、随机优势试验,参与者于 2017 年 11 月 20 日至 2020 年 4 月 9 日入组。合格的参与者年龄在 13 至 17 岁之间,符合非自杀性自伤障碍的诊断标准;他们是作为连续患者和志愿者的混合队列入组的。父母与他们的孩子一起参与。主要终点是治疗后 1 个月。参与者在治疗后 3 个月进行随访。数据收集于 2021 年 1 月结束。
为期 12 周的治疗师指导的、互联网提供的情绪调节个体治疗,作为辅助治疗常规治疗与常规治疗仅接受治疗。
主要结果是青少年版故意自我伤害清单,由参与者在治疗前、治疗期间每周一次以及治疗后 4 周自我报告,由盲法评估者在治疗前和治疗后 1 个月和 3 个月进行临床评估。
共有 166 名青少年(平均[SD]年龄,15.0[1.2]岁;154[92.8%]名女性)被随机分配到接受互联网提供的情绪调节治疗加常规治疗(84 名参与者)或仅接受常规治疗(82 名参与者)。实验组在减少临床评估的非自杀性自伤方面优于对照组(82%比 47%的减少;发病率比,0.34;95%置信区间,0.20-0.57),从治疗前到 1 个月后。这些结果在 3 个月后仍保持不变。在治疗过程中,情绪失调的改善介导了自我伤害的改善。
在这项随机临床试验中,为期 12 周的、治疗师指导的、互联网提供的情绪调节治疗,作为常规治疗的辅助治疗,在减少自伤方面是有效的,中介分析支持了情绪调节作为这种治疗中变化机制的理论作用。这种治疗方法可能会增加对有非自杀性自伤的青少年进行循证心理治疗的机会。
ClinicalTrials.gov 标识符:NCT03353961。